HD-OPM Archive
Topics › Brain health & dementia

High-dose DHA did not slow cognitive decline in 2-year APOE4 trial, but reached the brain

Louis Nervegna · Jun 27, 2026 · ♥ 7 reactions · 0 comments · original Facebook post
Brain health & dementiaSupplements & vitaminsFats & oils (saturated fat, seed oils, omega-6, olive oil)
AI summary & key facts

Louis comments on a Medscape report of a trial of high-dose omega-3 in older adults at high dementia risk. It found no improvement in memory, cognition or hippocampal volume, although DHA reached the cerebrospinal fluid equally in APOE4 carriers and non-carriers. He notes the trial was short at two years, and APOE4 carriers with the highest DHA to arachidonic acid ratio declined less.

It was a short trial. Only 2 years.

On a positive note, APOE4 carriers with the highest ratio of DHA to AA (arachodonic acid) did show less cognitive decline in the trial, relative to carriers with the lowest ratio.

See this previous post, describing the trial in more detail: ↪ PREVENT-E4: 2 g/day DHA did not slow cognitive decline in 365 at-risk older adults.

Another positive finding was that cerebral spinal fluid (CSF) levels of DHA were just as high in APOE4 carriers as in non-carriers, dispelling the myth that high-dose DHA (2g) does not cross the blood brain barrier very well in APOE4’s. This trial proved definitively that it does.

#dhaHD #fishoilHD #omega3HD #prevente4HD #alzheimersHD #dementiaHD #apoe4HD #hippocampusHD #arachadonicacidHD

Research cited

Shared from Medscape · original post

High-dose omega-3 supplements were not associated with improved memory or cognitive function in cognitively unimpaired older adults at high risk for dementia, a new clinical trial suggested. While researchers found evidence of the omega-3 docosahexaenoic acid in cerebrospinal fluid — indicating the nutrient reached the brain — it didn’t translate to benefits in hippocampal volume or cognitive performance.

There was also no association with decreased brain cell loss in areas of the brain related to Alzheimer’s disease, regardless of APOE epsilon 4 status. Read more about the research by tapping the link: Does High-Dose Omega-3 Benefit Cognition in Older Adults? (Medscape)

No photo description available.
← newer: Omega-3 at 1-2 g/day reduced PMS severity in a 2022 meta-anaolder: Low-inflammatory diets linked to up to 30% lower dementia ri →